Ethanol

Selected form

Ethanol

Treatment option: Mastitis, Felon, Furuncle

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ethanol

Quick Facts

Property	Description
Active Ingredient	Ethanol (Ethyl alcohol, C2H5OH)
Form	Aqueous Solution (Diluted Alcohol)
Pharmacological Class	Central Nervous System (CNS) Depressant; Antiseptic/Disinfectant
Common Purpose	Antiseptic skin preparation; Toxic alcohol antidote
Origin	Natural (fermentation) or Synthetic

What is Ethanol? Identity, Composition, and Origin

Ethanol, known chemically as Ethyl alcohol, is a foundational organic compound and a volatile liquid used extensively in medicine as both an Active Ingredient and a pharmaceutical Solvent. It is a simple two-carbon alcohol that can be derived from the natural fermentation of sugars or produced synthetically. The substance is clinically recognized for its rapid antimicrobial action against a wide spectrum of bacteria and viruses. For medical applications, the substance's purity must strictly adhere to official Pharmacopeia standards.

Ethanol's Unique Classification in Medicine

Ethanol holds a unique dual classification in medicine based on its primary physiological effects. When absorbed into the bloodstream, it functions as a Central Nervous System (CNS) Depressant. When applied locally, it is classified as a potent Antiseptic/Disinfectant. This dual role is a key differentiating factor among medicinal alcohols. This allows the substance to be administered via the Topical route for non-prescription uses, such as preparing skin before minor procedures, or by the Oral or Intravenous route when used as an essential Antidote.

General Medical Purpose and Mechanism Principle

The general medical purpose of Ethanol is characterized by its capacity for effective skin disinfection and its function as a specialized Antidote for certain alcohol poisonings. Its local antiseptic action is achieved through Protein Structure Disruption, which rapidly destroys the cell structures of microorganisms on contact. Its systemic purpose relies on Competitive Blockade, a mechanism that actively prevents the body from converting toxic alcohols, such as methanol and ethylene glycol, into highly damaging substances, thus serving as a crucial, life-saving chemical buffer.

What side effects are possible with Ethanol?

Possible Side Effects and Safety Information

The official safety profile for systemic Ethanol is largely defined by its function as a Central Nervous System (CNS) depressant and the critical need for continuous monitoring, as documented in regulatory prescribing information. The adverse reactions are classified across several physiological systems.

Documented Adverse Reactions and Safety Concerns

The most common adverse reactions listed in the regulatory label for systemic administration are related to CNS depression. These reactions include flushing, throbbing headache, nausea, vomiting, tachycardia (rapid heartbeat), diaphoresis (sweating), and hypotension (low blood pressure). Effects are also noted in the Nervous System (e.g., confusion, tremors) and Respiratory system (e.g., dyspnea).

Serious adverse reactions listed in official documents include dose-dependent CNS and respiratory depression, Ethanol Toxicity, and the risk of QT interval prolongation, a cardiac safety concern. The risk of acetaldehyde accumulation is also noted, particularly in individuals with a history of ethanol intolerance.

Population-Specific Safety Constraints

Specific safety considerations are mandated for certain populations. Pregnancy testing is recommended for females of reproductive potential prior to treatment, as use may be associated with Embryo-Fetal Toxicity. For neonates and infants, the use of solutions containing the excipient benzyl alcohol has been linked to the risk of systemic toxicity, including the “gasping syndrome.”

Mandatory Regulatory Safety Monitoring

The official safety requirements impose specific constraints during administration. Continuous monitoring of plasma ethanol and toxic alcohol concentrations, ECG monitoring for cardiac stability, and fluid volume status checks are required throughout treatment to manage the risk of toxicity and fluid overload. Co-administration with certain disulfiram-like drugs is listed as a safety restriction.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose involving ethanol is documented in regulatory sources as a critical event characterized by severe central nervous system (CNS) depression and metabolic disturbances. Seeking immediate medical attention is the mandatory action when an overdose is suspected due to the potential for life-threatening outcomes.

Clinical Domain	Regulator-Listed Manifestations
Neurological	Confusion, stupor, coma, somnolence, and general CNS depression.
Cardiopulmonary	Hypotension (low blood pressure), hypothermia (low body temperature), and respiratory depression.
Metabolic	Severe metabolic acidosis and hypoglycemia (low blood sugar), which are formally described physiological findings in overdose cases.

Urgent medical help must be sought if symptoms include coma, severe respiratory depression, or loss of consciousness. The most severe outcome is respiratory failure. Management is primarily symptomatic and supportive, addressing the severe clinical manifestations and correcting metabolic abnormalities. Official labeling states that no specific pharmacological antidote is known for pure ethanol overdose. Hospital monitoring, including frequent checks of vital signs and laboratory findings, is required. Increased severity of CNS effects may be noted in pediatric, elderly, and those with pre-existing hepatic or renal impairment.

Therapeutic Uses of Ethanol

What Ethanol Treats: Main Uses and Benefits

Ethanol is used across two distinctly different clinical scenarios, generally providing systemic protective support or localized preventative care. These primary uses define its therapeutic scope.

This substance is commonly used in acute situations that include the acute management of specific toxic alcohol ingestion (such as Methanol and Ethylene glycol poisoning). In the emergency setting, its application provides supportive relief by focusing on the chemical processes linked to toxic compounds within the body. This provides support that helps manage the systemic burden and assists with mitigating the risk of injury to organs.

Regarding local contexts requiring the reduction of surface microbial contamination risk, it is applied in scenarios such as preoperative preparation or for cleansing minor wounds. It is applied to address the concentration of pathogens on the skin, contributing to a safer procedure. This topical application helps reduce the microbial load and assists with minimizing the chance of localized infection at the site of skin breach.

Quick Fact: Relief for Key Symptom Domains
Systemic Domain	Support for severe metabolic instability and mitigating the risk of organ stress.
Local Domain	Support for surface microbial contamination and associated infection risk.

Regulatory References

NIH StatPearls overview on Ethanol

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Ethanol — official regulatory information

Regulatory documents establish specific rules regarding the use of ethanol, particularly its high-concentration prescription injection form and as an excipient in other medicines. These rules define who can use the medicine and who must avoid it.

Eligibility Scope

Classification	Populations and Conditions
Populations for Whom Use Is Allowed	Adults with symptomatic hypertrophic obstructive cardiomyopathy who are not candidates for surgical myectomy (for the prescription injection formulation ABLYSINOL^ ®).
Populations for Whom Use Is Contraindicated	Patients with known hypersensitivity to ethanol or any ingredients. Conditions include seizure disorder and diabetic coma (for the injection formulation). Subarachnoid injection is also contraindicated in patients receiving anticoagulants.
Populations for Whom Use Is Restricted	Use is generally not recommended in children unless necessary, and specific regulatory limits on alcohol concentration apply to over-the-counter liquid preparations based on age.

Special Considerations

Use requires caution in patients with conditions such as diabetes mellitus, gout, hepatic impairment, shock, and following cranial surgery.

Pregnancy and Lactation: Use during these periods requires caution. Regulatory documents cite ethanol as a known reproductive toxicant that may cause harm, including Fetal Alcohol Spectrum Disorders, upon ingestion.

What should I know about interactions with other medicines?

Ethanol Interactions with Other Medicines and Products

Official regulatory documents define several significant interaction patterns for Ethanol (Ethyl alcohol), primarily driven by its effects as a Central Nervous System (CNS) depressant and its role in hepatic metabolism.

Regulatory Interaction Classifications

Classification	Examples of Interacting Substances/Classes
Contraindicated	Flibanserin, Monoamine Oxidase Inhibitors (MAOIs), Disulfiram-like agents (e.g., Metronidazole).
Clinically Significant	CNS Depressants (e.g., specific Opioids, Benzodiazepines), Acetaminophen, NSAIDs, Warfarin.

Pharmacodynamic and Metabolic Constraints

The most critical constraint involves CNS Depressant Potentiation, which causes severe additive sedation and respiratory risk when combined with medications in this class, leading to formal prohibitions. Furthermore, Ethanol's metabolic influence is cited in the official warnings for Acetaminophen, where chronic consumption increases the risk of severe liver damage. This is linked to the induction of the CYP2E1 liver enzyme, which can also alter the clearance of other co-administered drugs.

Specific label-based cautions address Pharmacodynamic Risk Amplification, noting the increased risk of gastrointestinal bleeding with NSAIDs and altered anticoagulant effect with Warfarin. Regulatory guidance also specifies that antidiabetic medications require food co-ingestion with alcohol to mitigate the risk of hypoglycemia. Finally, official labeling includes specific notes for use in patients with Hepatic Impairment due to altered drug metabolism and clearance.

Mechanism of Action

How Ethanol Works

Ethanol primarily modulates the gamma-aminobutyric acid type A (GABAA) receptor, a ligand-gated ion channel, thereby altering central nervous system excitability. This allosteric modulation increases the GABAA receptor's affinity for its endogenous ligand, GABA. This interaction results in an increased influx of chloride ions ( Cl^-) across the neuronal membrane, causing hyperpolarization of the postsynaptic neuron and a subsequent reduction in overall excitatory neurotransmission.

In addition to potentiating inhibitory signaling, ethanol non-competitively inhibits the N-methyl-D-aspartate ( NMDA) receptor. Inhibition of the NMDA receptor reduces the conductance of calcium ions ( Ca^2+) into the cell, further contributing to decreased neuronal depolarization and electrical activity. Ethanol also interacts with other targets, including 5- HT3 receptors and voltage-gated ion channels, and alters the fluidity of lipid membranes within the CNS neurons.

Dosage and Administration Information

How to Use Ethanol: Official Administration Guidelines

This medicine is administered under strict medical supervision and according to established medical protocols. The method of administration is either Intravenous (IV) Infusion for systemic use (e.g., in poisoning) or Injection into specific sites for neurolysis (pain management), such as near nerve tissues or into the subarachnoid space.

Administration Requirements

Administration Scope	Official Instruction
Route of Administration	Intravenous Infusion or Targeted Injection (Subarachnoid/Nerve)
Preparation Requirements	For IV use, the dehydrated alcohol (not less than 98%) must be diluted to 10% concentration before administration, typically in 5% Glucose Solution for Infusion.
Special Procedural Conditions	IV Infusion should preferably be via a central venous catheter. For subarachnoid injection, precise patient positioning is required due to the solution being hypobaric, and the injection must be made slowly.

Dosing and Timing

Dosing Parameter	Official Instruction (IV Infusion)
Dosing Schedule	A calculated loading dose of 600–800 mg/kg is administered, followed by a continuous maintenance infusion.
Infusion Rate	The continuous infusion rate must be carefully calculated and adjusted based on the patient’s clinical status, including whether they are a heavy drinker or undergoing hemodialysis.
Age-Group Rules	Dosing formulas provide separate calculations for the pediatric population (children), who follow the same maintenance rate as non-drinker adults.

These detailed instructions define the standardized and carefully controlled approach necessary for the proper use of this medicine, ensuring correct concentration, location, and rate of delivery.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ethanol

Evidence for Use in Acute Toxic Alcohol Poisoning

Research into Ethanol's role in managing poisoning from substances like Methanol and Ethylene Glycol was studied primarily through observational studies and retrospective case series in acute care settings. Since these are life-threatening medical emergencies, the conduct of randomized controlled trials (RCTs) where some patients would receive an inactive treatment is not considered feasible. Therefore, the evidence comes from studies that monitor and report on patient outcomes during the course of treatment.

Researchers have monitored how Ethanol use was associated with outcomes related to systemic or functional imbalance, particularly patient survival and the time needed to achieve metabolic stability (a key outcome reflecting physiological strain). The studies included adult patients with high severity and confirmed ingestion. The findings describe historical patterns observed in these studies, focusing on how metabolic measures evolved in the observed populations during the study period.

Evidence for Use in Antiseptic Skin Preparation

The evidence base for Ethanol's use as an antiseptic skin preparation before procedures is based on different kinds of research, including controlled volunteer trials and systematic reviews of clinical studies. Studies have explored comparing Ethanol-based preparations against other antiseptic agents in research exploring microbial contamination on the skin surface.

Research has monitored specific endpoints, including the measurements of microbial log reduction on the skin surface—a measure of immediate germ-killing activity—and, in clinical settings, the rates of Surgical Site Infection (SSI) in surgical patient populations. Studies consistently report findings related to immediate microbial reduction following application. The research highlights changes measured during the study period, showing that measured outcomes were highly dependent on the concentration of the alcohol and the application time.

Key Research Gaps and Remaining Uncertainties

A documented research gap is the absence of comparative evidence from RCTs for the antidotal use, which limits what is known about its comparison to newer treatment standards. For both applications, the evidence quality varies across studies, and findings are often subject to limitations such as modest sample sizes or the confounding factor of Ethanol being part of a multi-component treatment. Long-term effects and outcomes in specific patient subgroups are not fully characterized.

Key Studies & References

How should Ethanol be stored and disposed of?

How to Store and Dispose of Ethanol

Storage and disposal of ethanol must strictly follow regulatory guidance due to its classification as a highly flammable liquid and vapor. The primary goal is to maintain product stability and prevent fire hazards.

Official Storage and Handling

Ethanol must be kept in a cool, well-ventilated place and the container must be kept tightly closed. Storage must be away from heat, sparks, open flames, and all ignition sources, and the product should be protected from sunlight. Precautions against static discharge are required for safe handling, including grounding and bonding containers. As with all medicines, it must be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired ethanol must not be washed away into the sewer or drain to prevent environmental contamination. Contents and containers must be disposed of at an approved waste disposal plant or industrial combustion facility, strictly according to local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Russia

A-Z Index:

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z